Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive type 2 Diabetes Management Algorithm – 2017 Executive Summary
Alan J. Garber(Baylor College of Medicine), Guillermo E. Umpierrez(Emory University), Jeffrey R. Garber(Harvard Vanguard Medical Associates), Irl B. Hirsch(University of Washington), Paul D. Rosenblit(University of California, Irvine Medical Center), Samuel Dagogo‐Jack(University of Tennessee Health Science Center), George Grunberger(Grunberger Diabetes Institute), Vivian Fonseca(Tulane University), Yehuda Handelsman(Tarzana Treatment Centers), Janet B. McGill(Washington University in St. Louis), Martin J. Abrahamson(Beth Israel Deaconess Medical Center), Paul S. Jellinger(University of Miami), Lawrence Blonde(Ochsner Medical Center), Jeffrey I. Mechanick(Icahn School of Medicine at Mount Sinai), Ralph A. DeFronzo(The University of Texas Health Science Center at San Antonio), Michael A. Bush(Cedars-Sinai Medical Center), W. Timothy Garvey(Indiana University – Purdue University Indianapolis), Joshua I. Barzilay(Kaiser Permanente), Daniel Einhorn(Diabetes & Endocrine Associates), Zachary T. Bloomgarden(Icahn School of Medicine at Mount Sinai)
Cited by 434
Related Papers
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
|Diabetes Care|2019|3.8k
Hyperglycemia: An Independent Marker of In-Hospital Mortality in Patients with Undiagnosed Diabetes
|The Journal of Clinical Endocrinology & Metabolism|2002|2.1k
Hyperglycemic Crises in Adult Patients With Diabetes
|Diabetes Care|2009|2k
International Consensus on Use of Continuous Glucose Monitoring
|Diabetes Care|2017|2k